European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission.

Bibliographic Details
Title:	European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission.
Authors:	Mahon, Francois-Xavier¹ (AUTHOR) francois-xavier.mahon@u-bordeaux.fr, Pfirrmann, Markus² (AUTHOR), Dulucq, Stéphanie^3,4 (AUTHOR), Hochhaus, Andreas⁵ (AUTHOR), Panayiotidis, Panayiotis⁶ (AUTHOR), Almeida, Antonio⁷ (AUTHOR), Mayer, Jiri⁸ (AUTHOR), Hjorth-Hansen, Henrik⁹ (AUTHOR), Janssen, Jeroen J.W.M.¹⁰ (AUTHOR), Mustjoki, Satu^11,12 (AUTHOR), Martinez-Lopez, Joaquin¹³ (AUTHOR), Vestergaard, Hanne¹⁴ (AUTHOR), Ehrencrona, Hans^15,16 (AUTHOR), Machová Poláková, Katerina¹⁷ (AUTHOR), Olsson-Strömberg, Ulla¹⁸ (AUTHOR), Ossenkoppele, Gert¹⁰ (AUTHOR), Berger, Marc G.¹⁹ (AUTHOR), Etienne, Gabriel^4,20 (AUTHOR), Dengler, Jolanta^21,22 (AUTHOR), Brümmendorf, Tim H.^23,24 (AUTHOR)
Source:	Journal of Clinical Oncology. 2024 Supplement 16, Vol. 42, p1875-1880. 11p.
Database:	Supplemental Index

More Details
ISSN:	0732183X
DOI:	10.1200/JCO.23.01647
Published in:	Journal of Clinical Oncology
Language:	English